7.Endocrine&Metabolic System
A. Oral Antidiabetic Agents
| Drug Name | Active Ingredient/Strength | Dosage Form/Route | Note |
|---|---|---|---|
Piotas Tablets 15 mg "P.L." |
Pioglitazone HCl……16.53mg (eq.to Pioglitazone……15mg) |
Tablet |
| Drug Name | Active Ingredient/Strength | Dosage Form/Route | Note |
|---|---|---|---|
Piotas Tablets 30 mg "P.L." |
Pioglitazone HCl……33.06mg (eq.to Pioglitazone……30mg) |
Tablet | BE Approved |
| Drug Name | Active Ingredient/Strength | Dosage Form/Route | Note |
|---|---|---|---|
| Glucomine F.C. Tab. 250mg "P.L." | Metformin HCL......250mg | Film-Coated Tablet | Dissolution Rate Profile |
| Glucomine F.C. Tab. 500mg "P.L." | Metformin HCL......500mg | Film-Coated Tablet | BE Approved |
| Glucomin X.R. Tab. 500mg "P.L." | Metformin HCL......500mg | Extended-Release Tablet | BE Approved |
| Diabes Tab. "P.L." | Glipizide......5mg | Tablet |
B. Antihyperlipidaemic Agents
| Drug Name | Active Ingredient/Strength | Dosage Form/Route | Note |
|---|---|---|---|
| Lipolin Cap. 100mg "P.L." | Fenofibrate......100mg | Capsule | BE Approved |



Piotas Tablets 15 mg "P.L."
Piotas Tablets 30 mg "P.L."

